Lynne Jesaitis

2.3k total citations · 1 hit paper
11 papers, 1.4k citations indexed

About

Lynne Jesaitis is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lynne Jesaitis has authored 11 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Lynne Jesaitis's work include Lysosomal Storage Disorders Research (5 papers), Trypanosoma species research and implications (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Lynne Jesaitis is often cited by papers focused on Lysosomal Storage Disorders Research (5 papers), Trypanosoma species research and implications (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Lynne Jesaitis collaborates with scholars based in United States, Canada and United Kingdom. Lynne Jesaitis's co-authors include James M. Anderson, Alan S. Fanning, Daniel A. Goodenough, Warren J. Gallin, Bruce R. Stevenson, Becky Schweighardt, Troy Tompkins, Charles O’Neill, Adam J. Shaywitz and Kehu Yang and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Genetics.

In The Last Decade

Lynne Jesaitis

11 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Tight Junction Protein ZO-1 Establishes a Link between the Transmembrane Protein Occludin and the Actin Cytoskeleton

1998 1.2k citations Alan S. Fanning, Lynne Jesaitis et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynne Jesaitis United States	9	780	734	218	205	119	11	1.4k
Kazuaki Umeda Japan	11	920 1.2×	1.0k 1.4×	131 0.6×	427 2.1×	129 1.1×	13	1.6k
Susanne Milatz Germany	16	1.0k 1.3×	860 1.2×	103 0.5×	123 0.6×	87 0.7×	20	1.5k
Catalina Flores-Maldonado Mexico	17	410 0.5×	752 1.0×	64 0.3×	150 0.7×	100 0.8×	32	1.1k
Mayumi Nakayama Japan	10	563 0.7×	631 0.9×	72 0.3×	190 0.9×	84 0.7×	10	1.0k
Fumiya Obata Japan	22	374 0.5×	682 0.9×	362 1.7×	163 0.8×	74 0.6×	64	2.1k
Christina Van Itallie United States	4	831 1.1×	764 1.0×	74 0.3×	180 0.9×	117 1.0×	5	1.3k
Nayden G. Naydenov United States	21	201 0.3×	529 0.7×	101 0.5×	275 1.3×	72 0.6×	39	1.0k
Socorro Islas Mexico	12	483 0.6×	521 0.7×	48 0.2×	144 0.7×	88 0.7×	12	910
Fabio D’Atri Italy	10	511 0.7×	616 0.8×	65 0.3×	247 1.2×	112 0.9×	10	914
Pascal Leblanc France	21	189 0.2×	1.0k 1.4×	208 1.0×	83 0.4×	90 0.8×	46	1.4k

Countries citing papers authored by Lynne Jesaitis

Since Specialization

Citations

This map shows the geographic impact of Lynne Jesaitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne Jesaitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne Jesaitis more than expected).

Fields of papers citing papers by Lynne Jesaitis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne Jesaitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne Jesaitis. The network helps show where Lynne Jesaitis may publish in the future.

Co-authorship network of co-authors of Lynne Jesaitis

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne Jesaitis. A scholar is included among the top collaborators of Lynne Jesaitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne Jesaitis. Lynne Jesaitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

deHart, Gregory W., et al.. (2018). Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay. Journal of Visualized Experiments. 1 indexed citations

2.

deHart, Gregory W., et al.. (2018). Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay. Journal of Visualized Experiments. 3 indexed citations

3.

Hendriksz, Christian J., Saikat Santra, Simon Jones, et al.. (2018). Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5 years of treatment. Molecular Genetics and Metabolism. 123(4). 479–487. 21 indexed citations

4.

Melton, Andrew C., Troy Tompkins, Brian Long, et al.. (2016). Antibodies that neutralize cellular uptake of elosulfase alfa are not associated with reduced efficacy or pharmacodynamic effect in individuals with Morquio A syndrome. Journal of Immunological Methods. 440. 41–51. 14 indexed citations

5.

Long, Brian, Troy Tompkins, Celeste Decker, et al.. (2016). Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study. Clinical Therapeutics. 39(1). 118–129.e3. 26 indexed citations

6.

Schweighardt, Becky, Troy Tompkins, Lynne Jesaitis, et al.. (2014). Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial. Clinical Therapeutics. 37(5). 1012–1021.e6. 46 indexed citations

7.

Musson, Donald G., Becky Schweighardt, Troy Tompkins, et al.. (2014). Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients with Morquio A Syndrome. Clinical Pharmacokinetics. 53(12). 1137–1147. 36 indexed citations

8.

Rice, Audie, Myles Dillon, Anne van Abbema, et al.. (2006). Eradication of Tumors in Pre-Clinical Models of Multiple Myeloma by Anti-CS1 Monoclonal Antibody HuLuc63: Mechanism of Action Studies.. Blood. 108(11). 3503–3503. 8 indexed citations

9.

Osmont, Karen S., Lynne Jesaitis, & Michael Freeling. (2003). The extended auricle1 (eta1) Gene Is Essential for the Genetic Network Controlling Postinitiation Maize Leaf Development. Genetics. 165(3). 1507–1519. 10 indexed citations

10.

Fanning, Alan S., et al.. (1998). The Tight Junction Protein ZO-1 Establishes a Link between the Transmembrane Protein Occludin and the Actin Cytoskeleton. Journal of Biological Chemistry. 273(45). 29745–29753. 1152 indexed citations breakdown →

11.

Jesaitis, Lynne, et al.. (1996). The Tight Junction Protein ZO-2 Contains Three PDZ (PSD-95Discs-LargeZO-1) Domains and an Alternatively Spliced Region. Journal of Biological Chemistry. 271(42). 25723–25726. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact